医疗瘤学质量改善干预措施的实施:系统性审查
Georgia Zachou1,2, Sukumar S Sugeeta1,2, Joanna Dodkins1,2
1National Cancer Audit Collaborating Centre, Clinical Effectiveness Unit, Royal College of Surgeons of England, London, United Kingdom.
JCO oncology practice
|July 17, 2025
概括
医疗瘤学的质量改进 (QI) 研究是有限的,尽管癌症率不断上升. 这次审查确定了28种系统抗癌疗法 (SACT) 的QI干预措施,所有这些都显示出积极的结果,但由于研究的局限性而缺乏概括性.
科学领域:
- 在瘤学瘤学.
- 改善医疗保健质量 改善医疗保健质量
- 系统性抗癌疗法 (SACT) 提供
背景情况:
- 全球癌症发病率正在增加,需要高质量的全身抗癌疗法 (SACT).
- 医疗瘤学的质量改善 (QI) 研究目前是有限的.
- 了解当前的QI干预措施对于改善患者的治疗结果至关重要.
研究的目的:
- 系统地识别和描述医学瘤学中的QI干预措施.
- 分析与SACT质量缺陷相关的干预类型,方法和结果.
- 为未来的瘤学QI研究和实践提供信息.
主要方法:
- 按照PRISMA指南,对EMBASE和MEDLINE (2000-2024) 进行系统的文献搜索.
- 包括评估医学瘤学中的QI干预措施的研究,包括基线测量和预定义的质量缺陷目标.
- 使用QI最低质量标准集 (QI-MQCS) 来提取研究设计,干预,质量缺陷,结果和评估的数据.
主要成果:
- 28项研究符合纳入标准,确定了五个关键QI主题:等待时间,SACT启动延迟,利用,副作用和安全性.
- 大多数研究都是单一中心和美国的,国家层面的研究有限.
- 所有干预措施都对至少一个与患者相关的结果产生了积极影响,其QI-MQCS得分高 (11-16/16).
结论:
- 尽管癌症治疗方法在不断发展,但医学瘤学的智商策略尚未得到充分探索.
- 已识别的智商干预措施显示有好处,但研究设计和设置限制了概括性.
- 在全球范围内扩大QI研究,更强大的方法和对培训/基础设施的投资对于改善瘤护理至关重要.
相关概念视频
01:21Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:30Health Information Technology and Healthcare Information System
929
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
929
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K